BanuAygunMD
Pediatric Hematology & Oncology • New Hyde Park, NYPediatric Anemia and Red Blood Cell Hematology, Pediatric Platelet Disorder Hematology
Associate Chief, Hematology Section Head, Sickle Cell Disease
Dr. Aygun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
269-01 76th Avenue
New Hyde Park, NY 11040Phone+1 718-470-3460Fax+1 718-343-4642
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterFellowship, Pediatric Hematology/Oncology, 1997 - 2000
University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 1994 - 1997
Hacettepe University FOMClass of 1992
Certifications & Licensure
NY State Medical License 2000 - 2025
TN State Medical License 2007 - 2014
IL State Medical License 1999 - 2005
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease Start of enrollment: 2006 Mar 03
- The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2 Start of enrollment: 2010 May 01
- Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias Start of enrollment: 2014 Apr 17
- Join now to see all
Publications & Presentations
PubMed
- PIVOTing the Course of HbSC Disease.Abena Appiah-Kubi, Banu Aygun
NEJM Evidence. 2025-02-01 - 1 citationsAssessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy-based refill records.Arlene Smaldone, Deepa Manwani, Banu Aygun, Abena Appiah-Kubi, Kim Smith-Whitley
Pediatric Blood & Cancer. 2024-09-01 - 3 citationsHealth Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report.Amber M Yates, Banu Aygun, Rachelle Nuss, Zora R Rogers,
Pediatrics. 2024-08-01
Abstracts/Posters
- Benefit and Safety of Isovolemic Hemodilution Prior to Red Cell Exchange in Chronically Transfused Sickle Cell PatientsBanu Aygun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Effects of Hydroxyurea Treatment on Malaria Infections in Sub-Saharan AfricaBanu Aygun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Splenomegaly in Children with Sickle Cell Anemia Receiving Hydroxyurea in Sub-Saharan AfricaBanu Aygun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
First Patient Cured of Sickle Cell AnemiaMarch 18th, 2025
Gene Therapy Delivers Alternative Sickle Cell Cure in USMarch 16th, 2025
Long Island Man Is First in New York History to Be Cured of Sickle Cell AnemiaMarch 13th, 2025- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
